Diazyme Laboratories
Generated 5/10/2026
Executive Summary
Diazyme Laboratories is a privately held diagnostic reagent company headquartered in San Diego, California. Founded in 1998, the company develops and manufactures high-quality enzyme and immunoassay reagents for automated clinical analyzers, serving healthcare professionals globally. Its proprietary technologies address critical needs in clinical chemistry, with a broad product portfolio that includes reagents for cardiac, diabetes, thyroid, and other disease markers. Diazyme's strong focus on innovation and quality has earned it a reputation as a reliable partner for hospitals and reference laboratories. Despite being private, the company has maintained steady growth by expanding its distribution network and investing in R&D.
Upcoming Catalysts (preview)
- Q2 2026Launch of next-generation cardiac assay panel70% success
- H2 2026Strategic distribution partnership in Asia-Pacific60% success
- Q1 2027FDA clearance for expanded autoimmune test menu50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)